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ABSTRACT
Introduction In the USA, transgender women are among 
the most vulnerable to HIV. In particular, transgender 
women of colour face high rates of infection and low 
uptake of important HIV prevention tools, including pre- 
exposure prophylaxis (PrEP). This paper describes the 
design, sampling methods, data collection and analyses 
of the TURNNT (‘Trying to Understand Relationships, 
Networks and Neighbourhoods among Transgender 
women of colour’) study. In collaboration with communities 
of transgender women of colour, TURNNT aims to explore 
the complex social and environmental (ie, neighbourhood) 
structures that affect HIV prevention and other aspects of 
health in order to identify avenues for intervention.
Methods and analyses TURNNT is a prospective cohort 
study, which will recruit 300 transgender women of colour 
(150 Black/African American, 100 Latina and 50 Asian/
Pacific Islander participants) in New York City. There will 
be three waves of data collection separated by 6 months. 
At each wave, participants will provide information on 
their relationships, social and sexual networks, and 
neighbourhoods. Global position system technology will 
be used to generate individual daily path areas in order 
to estimate neighbourhood- level exposures. Multivariate 
analyses will be conducted to assess cross- sectional and 
longitudinal, independent and synergistic associations of 
personal relationships (notably individual social capital), 
social and sexual networks, and neighbourhood factors 
(notably neighbourhood- level social cohesion) with PrEP 
uptake and discontinuation.
Ethics and dissemination The TURNNT protocol 
was approved by the Columbia University Institutional 
Review Board (reference no. AAAS8164). This study will 
provide novel insights into the relationship, network and 
neighbourhood factors that influence HIV prevention 
behaviours among transgender women of colour and 
facilitate exploration of this population’s health and 
well- being more broadly. Through community- based 
dissemination events and consultation with policy 
makers, this foundational work will be used to guide the 
development and implementation of future interventions 
with and for transgender women of colour.
BACkgRound
Around the world, transgender women (those 
assumed male at birth who come to under-
stand themselves as female) face unique 
barriers to their health and well- being. In 
the USA, these barriers most commonly 
Strengths and limitations of this study
 ► Focus on transgender women of colour, the popula-
tion most- affected by HIV in the USA.
 ► Through close collaboration with communities of 
transgender women, recruitment methods, data col-
lection tools and dissemination activities have been 
tailored to the lives of transgender women of colour.
 ► Objective measures (global positioning systems) 
of individual movements to more accurately as-
sess spatial behaviour and neighbourhood- level 
exposures.
 ► Opportunity for exploration of the factors that sup-
port and undermine health and well- being specific 
to but also well- beyond HIV for transgender women 
of colour.
 ► Study is limited by inclusion of only some racial and 
ethnic groups and the focus on a large urban centre 
that may not reflect transgender experiences in oth-
er parts of the USA.
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include access to services, experiences of stigma and 
discrimination, lack of medical and cultural compe-
tency among healthcare providers and socioeconomic 
constraints.1 Challenges such as these undermine many 
aspects of health but manifest profoundly in the odds of 
HIV, which among transgender women is estimated to 
be over 34 times higher than the general population of 
the USA.2 From an intersectional perspective, HIV not 
only disproportionately affects transgender women but 
in particular those of colour: a recent meta- analysis esti-
mated HIV prevalence to be significantly higher among 
Black (44.2%) and Latina transgender women (25.8%) 
when compared with White transgender women (6.5%).3 
Research has also found that transgender women of 
‘other’ racial backgrounds (including Asian and Pacific 
Islander) have higher rates of HIV than their White peers 
(9.8% vs 6.7%)3 and that Asian and Pacific Islander trans-
gender women may be more likely to engage in practices 
that increase risk of HIV, like condomless sex and illicit 
drug use.4
Research from the USA has found that transgender 
women of colour often have less access to and uptake of 
HIV prevention activities than their White peers.5 Notably, 
while HIV pre- exposure prophylaxis (PrEP) has emerged 
in recent years as a promising HIV prevention tool for 
transgender women,6 research has consistently found low 
awareness and uptake of the medication among trans-
gender women of colour.7–10 Interestingly, one study of 
Black cisgender gay and bisexual men and transgender 
women found that only a small minority were using PrEP 
even though most participants were aware of and willing 
to use the medication,11 further highlighting the need for 
more detailed understandings of the mechanisms for this 
disparity among transgender women specifically.
In recent years, researchers have paid increasing atten-
tion to HIV prevention and risk as it operates on many 
levels, including for relationships, networks of people 
and neighbourhoods.12 Specific to PrEP, emerging 
research from the USA suggests that characteristics of 
one’s social network can influence awareness and uptake 
among young cisgender gay and bisexual men13 14 and 
young transgender women.15 Similarly, another study 
found that PrEP awareness among young Black gay and 
bisexual men related both to their networks and also the 
density of health clinics in their home neighbourhoods.16 
The degree to which any of these relationships are rele-
vant to transgender women of colour, however, remains 
unknown, especially given the tendency of previous 
research to conflate populations of transgender women 
with those of cisgender gay and bisexual men.17 18 Further, 
research that permits causal inferences and accounts 
for the complexities of network and neighbourhoods is 
lacking; the existing literature, nevertheless, highlights 
the necessity of attending to network and neighbourhood 
predictors of PrEP uptake.
This paper describes the TURNNT (Trying to Under-
stand Relationships, Networks and Neighbourhoods 
among Transgender women of colour) study, which aims 
to establish a prospective cohort of HIV- negative trans-
gender women of colour in order to assess multilevel 
aspects of HIV prevention and risk. By employing an 
intersectional perspective19 within the context of a social 
ecological model,12 20 TURNNT will explore the complex-
ities, practices and power dynamics of individual trans-
gender women of colour as they live their lives within 
diverse networks and neighbourhoods of New York City.
METhodS And AnAlySES
Study aims
The aims of this study are to (1) investigate cross- sectional 
and longitudinal associations (independent and interac-
tional) between relationship, network and neighbour-
hood factors on PrEP uptake among transgender women 
of colour, and (2) investigate associations between rela-
tionship, network and neighbourhood factors and PrEP 
uptake and discontinuation among transgender women 
of colour.
Study design
This study comprises a prospective longitudinal 1- year 
cohort of transgender women of colour based in New 
York City.
Patient and public involvement
This project has been designed in close consultation 
with communities of transgender women of colour in 
New York City, adopting an explicitly community- based 
approach to research. During a 9- month consultation 
period, meetings were held with dozens of stakeholders 
representing different communities and organisations 
relevant to this study population. Organisations and indi-
viduals consulted included those providing health and 
other services to transgender women of colour, those 
involved with advocacy and support, social organisa-
tions, community groups and others. By holding these 
meetings early in the development of this project, the 
feedback was able to substantively inform all aspects of 
its design. For example, we amended survey questions 
around housing and home neighbourhoods after several 
community consultants made clear that housing stability 
was likely to be a significant challenge for a proportion of 
TURNNT participants. To ensure ongoing feedback and 
collaboration, a ‘Community Advisory Board’ comprising 
leaders of prominent transgender health, advocacy and 
support organisations in New York City was formed. This 
group will meet biannually over the course of the project 
to provide ongoing consultation on design, implementa-
tion, analysis, interpretation and dissemination, activities 
for which they are provided an annual stipend. At this 
project’s close, several community- based research dissem-
ination events will be hosted around New York City.
Participants
This study will recruit 300 transgender women of colour 
based in New York City. To be eligible for participation, 
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Figure 1 Overview of the TURNNT (Trying to Understand Relationships, Networks and Neighbourhoods among Trans women 
of colour) cohort study longitudinal data collection processes with 300 transgender women of colour in New York City, 2019–
2021
individuals must (1) be between 16 and 55 years old at 
baseline, (2) identify as a transgender woman, (3) be HIV 
negative, (4) identify as Black, African American, Latina, 
Latinx, Asian and/or Pacific Islander, (5) reside in New 
York City and (6) report no plans to move during the 
12- month study period. Participant age restrictions reflect 
that, among transgender women in the USA, 98% of HIV 
diagnoses occur among those aged 54 years and younger.21 
Of our total targeted sample of 300 participants, we will 
employ stratified sampling to recruit 150 Black or African 
American transgender women, 100 Latina or Latinx 
women and 50 Asian and Pacific Islander women. Partic-
ipants who report multiple racial or ethnic backgrounds 
will be counted as distinct from the categories outlined 
here and, as necessary, large groups of mixed racial back-
grounds will be used to form additional strata. Further, 
current clinical estimates from a large community health 
service in New York City suggest that 26% of sexually 
active transgender women of colour access PrEP;22 efforts 
will be made to slightly oversample PrEP users so that they 
comprise approximately one- third of the sample (n=100).
Recruitment and research interviews
TURNNT will undertake a multifaceted approach to 
recruitment. Recruitment will combine several different 
strategies in an effort to meet sample size targets and has 
been designed to reach diverse communities of trans-
gender women of colour, including along the lines of 
geography, age and social interests (eg, house ball scene, 
a chosen- family and event- driven subculture popular 
among young gay, lesbian and transgender people of 
colour23). Specific recruitment activities will include 
(1) paid advertising on social media, (2) distribution 
via existing online social groups, (3) print advertising 
distributed in health services and venues, (4) event- based 
recruiting and (5) referrals from transgender health and 
support organisations. The TURNNT Community Advi-
sory Board will provide guidance on venues and events 
most likely to reach the target population. All recruit-
ment efforts will direct to a dedicated study website ( 
www. turnnt. com) to assess eligibility and gather contact 
details, which will be used to arrange research interviews. 
To support those who may not have regular access to the 
internet, the eligibility survey will be completed as part of 
in- person recruitment efforts.
TURNNT interviews will be conducted in either English 
or Spanish by peers (ie, self- identified transgender 
women of colour) in a private interview space. To facili-
tate access, participants will be able to select where their 
interviews are conducted from among several geographi-
cally dispersed interview spaces located in offices, health 
services and community support centres around New 
York City. TURNNT has negotiated referral agreements 
with several primary care and sexual health services that 
specialise in caring for transgender women; in the event 
that participants express an interest in receiving PrEP, 
want clinical testing for HIV or other sexually transmis-
sible infections, or have other healthcare related needs 
or requests, research interviews will work with them to 
ensure appropriate referral to a partner service.
data collection
We will undertake three waves of data collection over 12 
months with each wave separated by a period of 6 months 
(figure 1). At each point, participants will provide four 
types of data—survey responses, GPS data, network details 
and HIV testing—linked by a unique participant identi-
fier assigned at baseline. Participants will have the option 
to conduct their interviews at locations in Manhattan, the 
Bronx, Queens or Brooklyn. Because GPS data will be 
collected over a 1- week period, each wave will be disag-
gregated into two visits separated by a period of at least 
1 week, which means that each participant will undertake 
six research interviews in total. For their time and travel 
expenses, participants will receive 50USD per research 
interview in wave 0 (baseline), 75USD per interview in 
wave 1 and 100USD per interview in wave 2. Participants 
who complete all three waves will receive an additional 
50USD at their final study visit (figure 1).
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Table 1 Social and sexual network member information to 
be collected from a sample of transgender women of colour 



















PrEP, pre- exposure prophylaxis.
Surveys
Participants will be invited to complete surveys admin-
istered during the first and second visits of each study 
wave. The first of these surveys will collect information on 
housing, perceptions of neighbourhood characteristics, 
stigma and discrimination, PrEP use, gender affirming 
processes, sexual practices, sex work, drug use and social 
capital. This same survey (excluding baseline demo-
graphic questions, like year of birth) will be repeated at 
each wave and, as such, all questions will be contextualised 
by 6- month timeframes (eg, ‘In the previous 6 months, 
how often have you…’). The second survey of each wave 
will be completed a week after the first and will focus on 
residential and work locations and movement patterns 
over the period since the first visit, information that will 
be used to complement the study’s GPS data. All surveys 
will be delivered via the digital platform Qualtrics, which 
facilitates skip patterns to avoid asking unnecessary ques-
tions. The surveys are disaggregated into sections, some 
of which are self- administered and others administered 
by a member of the research team. The survey instru-
ments can be completed in either English or Spanish and 
if a participant wishes, the entire survey can be admin-
istered by a member of the research team. The survey 
instruments were developed in close consultation with 
the Community Advisory Boards and were focus tested 
with four transgender women of colour (two Black and 
two Latina), for which they were compensated 50USD.
Information on relationships and social and sexual networks
At the second visit of each study wave, close- ended ques-
tions will be used to elicit details on participants’ rela-
tionships and specific members of their social and sexual 
networks. Participants will be asked about their platonic, 
romantic and sexual relationships, including if they have 
experienced intimate partner violence. For more detailed 
network analyses, we will employ a standard egocentric 
name generator approach whereby participants are asked 
to name as many of their friends and sexual partners as 
possible, which the interviewer will probe to get some 
sense of network sizes (ie, contacts) over the previous 
6 months. Following, participants will be asked to provide 
more detail on their five closest friends and five most 
recent sexual partners.24 This information will be used to 
define participants’ social and sexual networks, including 
any overlap between each network. Network details will 
be collected using a tool known as Network Canvas, soft-
ware designed to improve the collection of network data 
of these kind.25 Table 1 details the information that will 
be collected (if known) about each social and sexual 
network member.
GPS mobility details
At each wave, participants will also contribute data on their 
daily path areas via wearable GPS devices. GPS devices 
have been found to more accurately assess neighbour-
hood exposures than relying on participant recall26 or 
the use of administrative neighbourhood units.27 During 
the first visit of each wave, participants will be provided 
with a GPS device (Qstarz BT- Q1000XT, manufactured by 
Qstarz International Co., Ltd., Taipei, Taiwan), a charging 
cable and instructions on their use. Participants will be 
instructed to carry this device with them for 7 consecutive 
days, except when swimming and bathing, and to charge 
it overnight.
During the week between study visits, GPS devices will 
log participants’ coordinates (latitude and longitude) 
every 10 seconds, an interval selected to collect a large 
number of location points while respecting battery and 
data storage constraints. At the end of the 1 week period, 
participants will return the device, at which point their 
data will be extracted from the device, encrypted and 
added to the study database. A short survey will be admin-
istered to collect some basic details on where participants 
lived and worked during the week as well as general infor-
mation on their movement patterns (eg, travel outside 
New York City).
HIV testing
All HIV testing will be conducted in accordance with 
guidelines provided by the New York State Department 
of Health.28 During the first visit of each wave, a point- of- 
care rapid HIV test will be administered. All participants 
with reactive rapid tests will be immediately supported 
in accessing a service that can provide confirmatory 
HIV testing; TURNNT has agreements with several HIV 
testing sites around New York City to ensure that this can 
be done immediately following a reactive rapid test result. 
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Figure 2 Participant recruitment and attrition over time among a sample of 300 transgender women of colour in New York City, 
2019–2021
Any participant with confirmed HIV infection, including 
existing infection, will receive support to access HIV care. 
Participants will sign release of information forms that 
allows for sharing of clinic information (eg, linkage to 
care, treatment uptake, viral load) with the study team.
In-depth interviews for participants with HIV
Even though this project will employ an eligibility survey 
with information confirmed by a research assistant, it is 
possible that people living with a known HIV infection 
will present for participation. Participants with a known 
or new HIV infection will be invited to take part in an 
in- depth, semistructured interview on their experiences 
of being diagnosed and living with HIV, HIV care and 
management, relationships and networks, neighbour-
hoods and housing, experiences of stigma and discrimi-
nation and gender affirming care. Interviews will be audio 
recorded and transcribed, with participants compensated 
50USD for their time and travel expenses. Interviews 
will be conducted until 30 have been completed. After 
an interview and for any other participants diagnosed 
with HIV during the study period, participation will be 
discontinued.
Participant retention and attrition
This study will employ several processes to support partic-
ipant retention over 1 year of data collection, including 
(i) collection of multiple points of contact (eg, phone 
number, email, social media accounts), (ii) automated 
research interview reminder messages, (iii) check- in 
contact between study waves and (iv) text messages deliv-
ered every- other- day during the 1 week GPS period to 
reminder participants to carry and charge the devices. 
Despite these enhanced retention efforts, if approxi-
mately 10% of participants are lost- to- follow- up at each 
wave of data collection, then around 54 participants in 
total will discontinue participation. It is also expected that 
around 10% of participants at baseline will report with a 
known HIV infection (n=30) and that some people will 
be diagnosed with a previously unknown HIV infection 
at baseline or at subsequent study waves, which based 
on earlier HIV incidence estimates among transgender 
women (7.8 per 100 person years29) equates to approx-
imately 46 people. The expected attrition is detailed in 
figure 2, which with a starting sample of 300 people will 
result in a final sample of around 200 participants at the 
study’s close.
Timeline
Participants will provide 1 year of data over three time 
points. We will allow 18 months of data collection per 
wave, with the wave 0 baseline and recruitment period 
occurring from July 2019 to December 2020, wave 1 from 
December 2019 to July 2021 and wave 2 from July 2020 to 
December 2021. In total, data collection will span from 1 
July 2019 to 31 December 2021.
Study exposures and outcomes
Neighbourhood-level variables
In addition to socioeconomic status, TURNNT will focus 
on several neighbourhood- level factors with poten-
tial relevance to the general and HIV- specific health of 
transgender women of colour: social cohesion, violent 
crime, the presence of transgender health services and 
the presence of PrEP providers. Neighbourhood- level 
social cohesion will be assessed via items from the New 
York City Community Health Survey, which included 
four statements (eg, ‘People in your neighbourhood can 
be trusted’) with Likert- scale response options used to 
create an average of social cohesion by neighbourhood.30 
Statistics on violent crimes (ie, assault, murder, rape and 
robbery) are publicly available from the New York City 
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Police Department, which can be organised by neigh-
bourhood or geocoded to specific locations and, there-
fore, allow us to use either random effect econometric 
models or spatial interpolation techniques to assess 
neighbourhood cohesion levels. The presence of trans-
gender support services will be assessed using geocoded data 
compiled as part of TransAtlas, a location- based compen-
dium of health and support services for transgender and 
gender diverse people in New York City.31 Similarly, we 
will assess access to PrEP providers using geocoded data 
compiled by the Centers for Disease Control and Preven-
tion (AIDSVu), which we have used previously to conduct 
spatial analyses.32
Neighbourhood- level factors will be assessed at the level 
of individual participants using their residential address 
or where they sleep most of the time (provided during 
the survey) and GPS- defined activity spaces (ie, the areas 
within which people move during their daily activities). 
‘Home neighbourhoods’ will be created as a buffered area 
of 200, 400 and 800 m around each participants’ home 
address. Additionally, data collected from a participant’s 
GPS device will be used to define their neighbourhood 
exposures as determined by their activity space within the 
daily path area (ie, each participant’s trajectory through 
the world). In the calculation of these indicators in the 
daily path area, neighbourhood- level exposures will be 
weighted according to the time spent in each place in 
order to generate a time- weighted daily path area indi-
cator, reflecting that longer length of exposure is likely to 
have a greater impact on health and well- being.
Network-level variables
Several network- level variables will also be assessed 
for participant’s social and sexual networks, including 
social capital, sociodemographic homogeneity, social/
sexual network overlap and PrEP/HIV treatment access. 
Network- level social capital will be defined as the tangible 
and emotional support participants report is available 
from their network members (eg, ‘If needed, I could 
borrow $100 from this person’). Sociodemographic 
homogeneity will be defined as the proportion of social 
network members who report a similar age, gender, race/
ethnicity, HIV status and religious background to a partic-
ipant. Network overlap will be defined for each participant 
as the proportion of network members who are both a 
confidant and sex partner. PrEP/HIV treatment access will 
be defined as the proportion of a participant’s social and 
sexual networks who are reported as having accessed 
either PrEP or treatment for HIV.
PrEP outcome variables
This study will focus on two primary markers of PrEP 
access: uptake and discontinuation. PrEP uptake will 
be defined as participants who report using PrEP at any 
point during the study period, including at baseline. 
Incident PrEP uptake will be defined as participants who 
report not taking PrEP in wave 0 or 1 but subsequently 
report its use at wave 1 or 2. The second outcome, PrEP 
discontinuation, will focus on incident cases, defined as 
a participant who in wave 0 or 1 reports using PrEP but 
subsequently reports discontinuation in wave 1 or 2. PrEP 
use or discontinuation at each wave will also be analysed 
using repeated measure models, with the nested structure 
of successive measures for each participant accounted 
for with an individual random effect, thus increasing the 
overall power of our analyses. Other aspects of the PrEP 
continuum of care will be examined, including knowl-
edge, interest in and awareness of new PrEP modalities 
(eg, episodic, long- lasting injectable), barriers to use, 
self- reported adherence, and, as relevant, reasons for 
discontinuation (including concerns of interactions with 
feminising hormones).
Additional variables and covariates
TURNNT survey items will collect information on a 
diverse array of additional covariates previously shown to 
be of particular relevant to transgender women33 or likely 
to affect healthcare utilisation or health and well- being 
generally or specific to HIV. We will consider partici-
pant demographics (age, race/ethnicity, level of educa-
tion, annual income, access to food), housing (stability, 
time spent on the streets or in a homeless shelter), resi-
dential self- selection and history and healthcare access 
(insurance status, general access to healthcare). Covari-
ates relevant to gender affirmation will include the time 
since a participant started living as a gender other than 
was assigned at birth (or, as relevant, those who do not), 
access to transgender- specific healthcare and processes of 
gender affirmation.
TURNNT will also collect information on external 
stigma and discrimination, borrowing from existing 
measures for transgender women34 and people of 
colour;35 participants will also be asked some questions 
that assess internalised transphobia36 and racism. Mental 
health will be assessed using the K10 mental health 
index,37 while sexual practices will include involvement 
with sex work, sexual partner numbers, sexual partner 
gender(s) and condomless anal and vaginal sex. Drug use 
will be assessed in terms of frequency and drugs used, use 
of injecting drugs and in the context of sex. The survey 
will also include items on sleep quality and length from 
the widely used Pittsburgh Sleep Quality Index.38 Finally, 
we will assess participants experiences of incarceration, 
including length of time, experiences of violence and 
access to care.
Analyses
To address this study’s aims, the following analyses will 
be conducted. First, associations between relationship, 
network and neighbourhood factors and PrEP uptake 
will be evaluated by χ2 tests for categorical variables and 
Wilcoxon rank sum tests for continuous variables. Those 
variables with a significance of p<0.1 in the bivariate anal-
yses and other variables shown in the literature to be 
associated with PrEP uptake will be included as predic-
tors in a subsequent, cross- sectional binomial regression 
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analysis. Third, we will conduct a Poisson regression anal-
ysis with the number of incident cases of PrEP uptake 
as the outcome variable while controlling for poten-
tial confounding variables, as described above. Fourth, 
another Poisson regression analysis will be conducted 
with the number of incident cases of PrEP discontinu-
ation as the outcome. Because we expect that the GPS- 
defined variables will demonstrate some degree of spatial 
autocorrelation,27 as appropriate we will employ spatial 
autoregressive models to account for the clustered nature 
of the neighbourhood- level factors described above. 
Further, with an appreciation for the intersectional 
nature of several key factors (among them age, race, 
ethnicity and incarceration status), additional analyses 
will seek to assess effect modification. Although there is 
no consensus among theorists and methodologists on the 
statistical approach that is most appropriate for approxi-
mating intersectionality,39 our regression models will be 
modified through multiplicative interaction terms, strat-
ification and by assessing the effect modification of theo-
retically grounded intersectional terms.
While the previous analyses will focus on individual- 
level outcomes (one outcome for each participant 
defined cross- sectionally on the basis on responses to at 
least one of three waves), the data will also be analysed 
using a repeated measure model, with the three repeated 
measures for each individual, accounting for spatial, 
network and temporal autocorrelation. The latter model 
will allow us to account for both baseline characteristics 
and time- varying characteristics (eg, wave- specific daily 
path area variables and network variables). Through 
the utilisation of two distinct approaches to analysis, 
TURNNT will be able to ask a diverse host of questions 
and compare/contrast outcomes between different 
analytic techniques.
EThICS And dISSEMInATIon
A primary ethical concern for this project is the collec-
tion of highly sensitive, personal data from a population 
that often experiences stigma and discrimination. Specif-
ically, we will collect information on their sexual partners 
and behaviours and some questions will likely capture 
details on activities that are illegal in the state of New 
York, notably sex work and drug use. Recognising these 
potential sensitivities, all data will be stored in a de- iden-
tified format with access restricted only to members of 
the research team. Further, access to the study datasets 
will be automatically logged as a way to enhance trans-
parency and accountability. A ‘certificate of confidenti-
ality’ has been issued by the National Institutes of Health, 
which further protects participants by prohibiting the 
disclosure of information to anyone not involved in the 
research. Participants will be thoroughly briefed on these 
protections as part of the study onboarding and consent 
process. This study’s protocol and procedures have been 
reviewed and approved by the institutional review board 
of Columbia University (reference AAAS8164).
Through close and ongoing collaboration with commu-
nities of transgender women, TURNNT aims to produce 
research that is respectful and relevant while fostering 
pathways for disseminating findings directly to communi-
ties of need. Community- based dissemination events and 
forums will be held to share findings but also to engage 
participants and other members of New York City’s 
communities of transgender and gender diverse people 
in interpreting the results and suggesting subsequent 
actions. TURNNT’s approach to studying neighbour-
hoods will provide exciting new information that can be 
used to target interventions, improve service delivery and 
placement and characterise the neighbourhoods inhab-
ited by transgender women of colour. Further, through 
partnerships with scientific and policy experts, this 
project is well placed to feed its findings directly into the 
development, implementation and evaluation of novel 
relationship, network and neighbourhood- based HIV 
interventions.
dISCuSSIon
When taken regularly, PrEP has been shown to be highly 
effective at preventing HIV among transgender women,6 
but as a public health initiative, it is only effective if it 
is utilised by those most in- need. Transgender women of 
colour face some of the highest rates of HIV found in any 
population in the USA,3 but PrEP uptake and persistence 
is inconsistent with this vulnerability.6 11 By nesting an 
intersectional perspective within a social ecological model 
of health, TURNNT aims to generate new knowledge that 
can be used to address these gaps in PrEP uptake among 
transgender women of colour.
TURNNT will build on emerging literature that 
explores how the relationships and networks of trans-
gender women can influence their health and well- 
being,40–44 expanding it with an intersectional perspective 
and attention to new characteristics, including reli-
giosity, gender affirmation, racism and social capital. 
Promisingly, information on social and sexual networks 
is already being using to inform PrEP interventions for 
cisgender Black gay and bisexual men,45 suggesting that 
they may hold some potential for transgender women 
of colour if adapted to the specific needs of this popula-
tion. Further, TURNNT’s unique focus on the mobility 
of transgender women of colour will greatly expand our 
emerging understanding of the spatial aspects of HIV 
prevention. Relatedly, a key strength of this study is our 
use of GPS tracking to more accurately define the places 
where people spend their time, an approach that over-
comes the issue of ‘spatial polygamy’ (ie, the idea that our 
lives are spread across many spaces beyond just the area 
in which we live).46 47
This study has several methodological limitations that 
warrant consideration. First, although we have described 
TURNNT as a study of ‘transgender women of colour’, 
its sample is limited to those of Black, Latina, Asian and 
Pacific Islander background. It is likely that other racial 
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and ethnic minority transgender women have different 
experiences and exposures that could affect their health 
and well- being; future efforts to expand TURNNT to 
include transgender women of other racial and ethnic 
backgrounds are planned. Second, data will be collected 
only from people living in a densely populated urban 
centre, with experiences—particularly in the realm of 
neighbourhood environments—that may not reflect 
their peers in smaller cities and rural areas. Similarly, the 
unique social and political climates of New York City may 
make it difficult to generalise our findings to transgender 
women of colour in other cities, but as it is a centre of 
sexual and gender minority life in the USA, conducting 
research with the transgender women who live in New 
York City is as useful as a starting point for research of this 
kind. Third, this study is focused on transgender women 
and does not address the complexities and experiences 
of non- binary and other gender diverse people. Research 
that specifically addresses the needs of these populations 
is lacking and needed. Fourth, several cohort studies in 
general populations have included longer time periods 
than a single year, but given the expected mobility of this 
population,48 1 year is deemed the most feasible in order 
to ensure retention and this study’s overall feasibility.
There are many reasons to study the health and well- 
being of transgender women of colour, specific to and 
beyond HIV. Notably, the US Human Rights Campaign 
estimates that of the 26 known murders of transgender 
people in 2018, 20 were women of colour,49 a disturbing 
statistic that underscores the considerable inequities 
faced by these populations and the work yet- required to 
improve individual and public health for transgender 
women of colour. While TURNNT will contribute to the 
growing body of literature on how PrEP can be delivered 
effectively and efficiently, it also aims to address inequi-
ties in research, specifically the paucity of reliable data 
that can be used to illuminate and improve the lives and 
health of transgender women of colour. To that end, the 
data collected through this study as guided by a collabo-
rative of community stakeholders will have the potential 
to answer other questions about the positive and negative 
effects of neighbourhoods and networks on transgender 
women of colour, an important step towards improving 
diverse aspects of health and well- being for these women.
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